Contact Us | Useful Links | FAQs | Feedback | Sitemap |
 
   
 
Holdipharma Delegation gave a visit to the newdigging site of the Suez Canal :: Holdipharma welcomes the establishment of a production facility dedicated for production of raw materials :: Egyptian Exchange "Rings the Bell For Gender Equality " :: UNGC principles with holdipharma :: New chairman of Drug Holding Co. :: The Minister of the Business Sector is following up implementation plan :: Minister of Business Sector approved the estimated "DHC budget " 2017/2018 :: President Al Sisi directs the follow-up plans to develop public sector companies :: Minister of Business Sector receives Indian Ambassador :: Drug Holding Company: “Development Committee "ends the study of the Co. structure :: Ministry Of Public Business Sector: completion of the General Assemblies of DHCs :: Minister of Business Sector assigns 3 new members of Board of Directors of the DHC :: Chairman of Drug Holding Company: 11% is our share in the Egyptian drug market :: Captain Mohammed Wanees, one of the heroes of the glorious October War :: Minister of Business Sector: Restructuring the investment portfolio of the companies :: Appointment of a new President of the Drug Holding Company :: Hisham Anwar Tawfiq, Minister of Public Business sector, replacing Khaled Badawi . :: An integrated strategy for the advancement of the Drug Holding Company ::
 
 
Company Details
Company Name   Website
Misr   www.misrpharma.com.eg
     
Description

Misr Company for pharmaceutical industries was founded in 1939 as the first Egyptian company for the pharmaceutical production of human and veterinary drugs, and it was totally financed by a pure Egyptian capital through the contribution of "Misr Bank " that was established by the Great Egyptian economist "Talaat Pasha Harb" to be the first nucleus for developing the national projects and for the creation  of an Egyptian industry to compete against the foreign goods that were controlling the Egyptian and Arab Markets at that time.

In 1956, the company had established a new facility at Matariya area in accordance to the latest industrial system requirements and was provided with the latest machinery automation needed for the establishment of modern pharmaceutical industry.

The company played a very important national role in providing the Egyptian army with its medicinal needs during the several wars carried out by Egypt besides fulfilling its national duty by providing medicinal demands for all the Arab and African countries.

Misr is an owned state Company and one of the affiliated companies to Holdipharma company.

 And to help the company to continue its successful history initiated by the Egyptian leaders,it was decided to demolish its main headquarter in Matariya and  go through a complete renovation and modernization by the establishment of a new factory at Abu Zaabal district outside the densely populated area and in accordance to the latest GMP requirements and to be able to apply  the international quality standards with  a fully equipped production lines.

Misr Company is uniquely characterized by the existence of a dedicated manufacturing line for the production of penicillins (β-lactam antibiotics) with all its dosage forms to serve most of pharmaceutical companies as a toll manufacturer for this specialized production.

Misr company also owes a modernized well-equipped sterile areas built in accordance to the highest level of quality to manufacture ampoules, drops, sterile eye ointments and specialized surgical ampoules like morphine and pethidine , that are produced with complete control to ensure the quality and safety and with affordable price.

Misr Company as a core company started to export its pharmaceutical products since the forties of the last century that was widely created as a good distinguished reputation in the Arab and African pharmaceutical market.

Board Members:

Dr/ Amal Abdel Karim Abdel Wahed                   Chairman of the Board and Managing Director

Mr/ Yehia Mohamed Mahmoud                           Non Executive Member

Mr/ Foad Sakr Ahmed                                        Non Executive Member

Dr/ Hend Hussein Shaheen                               Elected Member

Mr/ Mohamed El Sayed Abdel Azeez                Elected Member

Audit Committee:

Mr/ Yehia Mohamed Mahmoud                   Chairman

Mr/ Ahmed Raslan                                   From Accountability State Authority (previously)      

Mr/ Foad Sakr Ahmed                              Non Executive Member

 

Company Main Indicators (in thousands of Egyptian Pounds)

Indicator

2014-2015

2015-2016

     2016-2017

Net Operating Revenue

   199861

   162041

             241846

Interest Expenses

   0

   0

                  0

Net Income

   (13869)

   (7993)

                1001

Net Equity

   257620

   248293

              239971

Working Capital

   26435

   28556

               30746

Total Investment

   264351

   255024

               246702

Salaries

   77664

   84610

                 95466

Number of workers

   1817

   1753

                 1689

     
Image Gallery
   
     
Related Links
Affiliates
   
Joint Venture
   
   
   
   
 
 
     
  Copyright © 2009 HOLDIPHARMA. All rights reserved.         Terms of Use | Privacy Statement | Disclaimer |